Crossmark Global Holdings’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-799
| Closed | -$38K | – | 1329 |
|
|
2023
Q4 | $38K | Sell |
799
-1
| -0.1% | -$48 | ﹤0.01% | 1296 |
|
|
2023
Q3 | $43K | Buy |
800
+10
| +1% | +$538 | ﹤0.01% | 1258 |
|
|
2023
Q2 | $121K | Buy |
790
+2
| +0.3% | +$306 | ﹤0.01% | 1281 |
|
|
2023
Q1 | $235K | Buy |
788
+1
| +0.1% | +$298 | 0.01% | 1156 |
|
|
2022
Q4 | $270K | Buy |
787
+8
| +1% | +$2.75K | 0.01% | 1057 |
|
|
2022
Q3 | $147K | Buy |
779
+24
| +3% | +$4.53K | ﹤0.01% | 1200 |
|
|
2022
Q2 | $159K | Buy |
+755
| New | +$159K | ﹤0.01% | 1234 |
|